Johnson & Johnson MedTech Global VP and Group Chief Information Officer Larry Jones [Photo courtesy of Johnson & Johnson]Johnson & Johnson (NYSE:JNJ) MedTech Global VP and Group Chief Information Officer Larry Jones appears to be leaving the world’s second-largest medical device manufacturer.

强生医疗科技全球副总裁兼集团首席信息官拉里·琼斯[照片由强生提供]强生（纽约证券交易所：JNJ）医疗科技全球副总裁兼集团首席信息官拉里·琼斯似乎即将离开这家世界第二大医疗器械制造商。

“After 35 incredible years at Johnson & Johnson, I find myself reflecting on the remarkable journey we’ve experienced together,” Jones said on LinkedIn today.

琼斯今天在LinkedIn上说：“在强生公司度过了难以置信的35年后，我发现自己在反思我们共同经历的非凡旅程。”。

“To my friends and partners throughout this journey, this isn’t a farewell — it’s simply a ‘see you later,'” he later continued, saying he was embarking on an “exciting new chapter of my life and professional journey.”

“在这段旅程中，对我的朋友和伴侣来说，这不是告别，只是‘再见’，”他后来继续说道，他正在开启“我生活和职业生涯中令人兴奋的新篇章”

It’s not clear whether Jones is retiring from the Johnson & Johnson medical device business, and if so when he’ll officially leave or if someone’s been named to replace him.

目前尚不清楚琼斯是否将从强生医疗器械公司退休，如果是的话，他什么时候正式离职，或者是否有人任命接替他。

J&J MedTech and Jones didn’t respond to messages seeking more information shortly after he posted the announcement, but we’ll update this story if we learn more.

强生医疗科技公司和琼斯在发布公告后不久没有回复寻求更多信息的消息，但如果我们了解更多信息，我们将更新此消息。

With more than $30 billion in annual sales, J&J MedTech is the world’s second-largest medical device business, according to Medical Design & Outsourcing‘s 2024 Medtech Big 100 ranking by revenue.

根据医疗设计与外包2024年医疗技术100强收入排名，强生医疗技术年销售额超过300亿美元，是世界第二大医疗器械企业。

“Our dedication to patients, community, customers, and employees has always been an inspiration, and I am immensely proud of our accomplishments,” Jones wrote in his LinkedIn post. “Our success stands as a testament to the amazing global teams and leaders with whom I’ve collaborated, creating a family-like atmosphere that made every challenge worthwhile.

琼斯在LinkedIn帖子中写道：“我们对患者、社区、客户和员工的奉献精神一直是一种鼓舞，我为我们取得的成就感到无比骄傲。”。“我们的成功证明了与我合作的令人惊叹的全球团队和领导者，创造了一种家庭般的氛围，使每一个挑战都值得。

… I carry with me countless cherished memories, stories, and experiences. Thank you so much.”.

…我随身携带着无数珍贵的记忆、故事和经历。非常感谢。”。

“I want to extend my heartfelt gratitude to my family for their steadfast support, especially to my wife-coach, whose love and encouragement have been invaluable,” he continued. “I also want to thank my dad for being a great, yet humble role model. He instilled in me a strong work ethic of commitment and grit.”.

他继续说道：“我要衷心感谢我的家人对我的坚定支持，尤其是我的妻子教练，他们的爱和鼓励是无价的。”。。

“As I embark on this exciting new chapter of my life and professional journey, I remain committed to using technology for good, advancing global health equity, and fighting chronic disease,” Jones concluded.

琼斯总结道：“当我开始人生和职业生涯中令人兴奋的新篇章时，我仍然致力于利用技术造福人类，促进全球健康公平，并与慢性病作斗争。”。

It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She stayed on as an advisor until February 2024 as Tim Schmid assumed leadership of the medical device business.

一年前的这个月，AshleyMcEvoy出人意料地宣布辞去强生医疗技术全球总裁的职务。由于蒂姆·施密德（TimSchmid）担任医疗器械业务的领导，她一直担任顾问，直到2024年2月。

Medtech pay analysis: J&J CEO pay doubled in 2023; Former J&J MedTech leader’s comp also climbed

Medtech薪酬分析：强生首席执行官的薪酬在2023年翻了一番；前强生医疗科技领导者的薪酬也有所攀升

On his LinkedIn page, Jones said his recent success included “completion of a 3 year, $200mm global digital transformation initiative to drive lean business processes, cloud-based solutions, and integrated insights.”

琼斯在LinkedIn页面上表示，他最近的成功包括“完成了一项为期3年、耗资2亿美元的全球数字转型计划，以推动精益业务流程、基于云的解决方案和综合见解。”

“Currently, he is focused on driving digital surgery connectivity solutions for the company’s surgical robotics and machine learning platforms in Oncology, Orthopedics, Cardiovascular, and general surgery,” his LinkedIn page said.

“目前，他专注于推动数字手术连接解决方案，用于该公司在肿瘤学、骨科、心血管和普通外科的手术机器人和机器学习平台，”他的LinkedIn页面说道。

Earlier this month, J&J submitted its Ottava surgical robot for FDA investigational device exemption (IDE), nearly three years after unveiling the six-armed system.

本月早些时候，强生公司在推出六臂系统近三年后，将其Ottava手术机器人提交给FDA研究设备豁免（IDE）。

Medical Design & Outsourcing interview: J&J MedTech’s Larry Jones imagines the future of cloud-connected medical devices

医疗设计与外包采访：强生医疗科技公司的拉里·琼斯（LarryJones）想象云连接医疗设备的未来